CARDIOVASCULAR DISEASE (CVD)
Clinical trials for CARDIOVASCULAR DISEASE (CVD) explained in plain language.
Never miss a new study
Get alerted when new CARDIOVASCULAR DISEASE (CVD) trials appear
Sign up with your email to follow new studies for CARDIOVASCULAR DISEASE (CVD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Two-Drug start be better for High-Risk PAH patients?
Disease control Recruiting nowThis study compares starting with two oral medications (tadalafil and ambrisentan) versus just one in people newly diagnosed with pulmonary arterial hypertension (PAH) who also have at least two heart-related conditions. The goal is to see if the combination therapy improves risk…
Matched conditions: CARDIOVASCULAR DISEASE (CVD)
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
Wearable tech to watch heart disease in 5,000 patients
Knowledge-focused Recruiting nowThis study will use wearable digital health devices to collect heart data from 5,000 adults with chronic heart conditions like heart failure, high blood pressure, and aortic stenosis. The goal is to observe how these conditions progress over time. No new treatments or medications…
Matched conditions: CARDIOVASCULAR DISEASE (CVD)
Sponsor: Prolaio • Aim: Knowledge-focused
Last updated May 17, 2026 00:46 UTC
-
Major study launches to uncover heart risks of Gender-Affirming hormones
Knowledge-focused Recruiting nowThis study follows 500 transgender adults who have been on gender-affirming hormone therapy for at least one year. Researchers will measure changes in blood pressure, cholesterol, body composition, and other heart health markers. The goal is to understand long-term cardiovascular…
Matched conditions: CARDIOVASCULAR DISEASE (CVD)
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC